ScinoPharm Taiwan Ltd (1789)

Currency in TWD
16.90
-0.25(-1.46%)
Closed·
1789 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
1789 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.9017.15
52 wk Range
16.2525.80
Key Statistics
Bid/Ask
27.10 / 27.15
Prev. Close
21
Open
17.15
Day's Range
16.9-17.15
52 wk Range
16.25-25.8
Volume
462.07K
Average Volume (3m)
762.42K
1-Year Change
-32.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1789 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.00
Upside
+42.01%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

ScinoPharm Taiwan Ltd Company Profile

ScinoPharm Taiwan, Ltd., together with its subsidiaries, research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally. The company provides small molecular drugs, protein drugs, complex natural molecules and derivatives, synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; outsourcing services. It offers CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates, as well as develops peptide synthesis technologies. In addition, the company develops and manufactures western medicines and other chemical materials, albumin and oligonucleotide medicines, and injections. as well as provides biological technology services, technical, and Intellectual property rights related services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.

Employees
540
Market
Taiwan

Compare 1789 to Peers and Sector

Metrics to compare
1789
Peers
Sector
Relationship
P/E Ratio
65.3x0.0x−0.5x
PEG Ratio
−1.300.000.00
Price/Book
1.3x0.0x2.6x
Price / LTM Sales
4.2x0.0x3.3x
Upside (Analyst Target)
42.0%0.0%43.3%
Fair Value Upside
Unlock0.0%6.9%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 24.00
(+42.01% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.25%
Dividend Yield
2.07%
Industry Median 2.51%
Annualised payout
0.35
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 06, 2025
EPS / Forecast
0.04 / 0.10
Revenue / Forecast
747.52M / 850.00M
EPS Revisions
Last 90 days

1789 Income Statement

FAQ

What Stock Exchange Does SPT Trade On?

SPT is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for SPT?

The stock symbol for SPT is "1789."

What Is the SPT Market Cap?

As of today, SPT market cap is 13.36B.

What Is SPT's Earnings Per Share (TTM)?

The SPT EPS (TTM) is 0.25.

When Is the Next SPT Earnings Date?

SPT will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is 1789 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has SPT Stock Split?

SPT has split 6 times.

How Many Employees Does SPT Have?

SPT has 540 employees.

What is the current trading status of SPT (1789)?

As of 11 Aug 2025, SPT (1789) is trading at a price of 16.90, with a previous close of 21.00. The stock has fluctuated within a day range of 16.90 to 17.15, while its 52-week range spans from 16.25 to 25.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.